TRAJECTORIES OF ANASTROZOLE ADHERENCE AND NEUROPSYCHOLOGICAL SYMPTOM BURDEN IN POSTMENOPAUSAL WOMEN WITH EARLY-STAGE BREAST CANCER 18-MONTHS POST-INITIATION OF AROMATASE INHIBITOR THERAPY

被引：0
|
作者：
McCall, Maura [1 ]
Rosenzweig, Margaret Quinn [2 ]
Conley, Yvette [2 ]
Beumer, Jan [2 ]
Sereika, Susan [3 ]
Bender, Catherine [3 ]
机构：
[1] Case Western Reserve Univ, Cleveland, OH USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
[3] Univ Pittsburgh, Sch Nursing, Pittsburgh, PA USA
来源：
ONCOLOGY NURSING FORUM | 2023年 / 50卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Anastrozole is safer and may be more effective than tamoxifen in postmenopausal women with early-stage breast cancer
    Carraway, H
    Wolff, AC
    CANCER TREATMENT REVIEWS, 2004, 30 (03) : 303 - 307
  • [22] Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer
    Crew, Katherine D.
    Greenlee, Heather
    Capodice, Jillian
    Raptis, George
    Brafman, Lois
    Fuentes, Deborah
    Sierra, Alex
    Hershman, Dawn L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (25) : 3877 - 3883
  • [23] Cost effectiveness of letrozole versus anastrozole in postmenopausal women with HR plus early-stage breast cancer
    Lipsitz, Michael
    Delea, Thomas E.
    Guo, Amy
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (10) : 2315 - 2328
  • [24] Effect of Aromatase Inhibitor Therapy on Sleep and Activity Patterns in Early-stage Breast Cancer
    Bhave, Manali A.
    Speth, Kelly A.
    Kidwell, Kelley M.
    Lyden, Angela
    Alsamarraie, Cindy
    Murphy, Susan L.
    Henry, N. Lynn
    CLINICAL BREAST CANCER, 2018, 18 (02) : 168 - +
  • [25] Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: A review of the evidence
    Litsas, Georgia
    ONCOLOGY NURSING FORUM, 2008, 35 (04) : 714 - 721
  • [26] Impact of chemotherapy on symptoms and symptom clusters in postmenopausal women with breast cancer prior to aromatase inhibitor therapy
    Li, Hongjin
    Sereika, Susan M.
    Marsland, Anna L.
    Conley, Yvette P.
    Bender, Catherine M.
    JOURNAL OF CLINICAL NURSING, 2019, 28 (23-24) : 4560 - 4571
  • [27] The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy
    Nugent, Bethany D.
    Sereika, Susan M.
    Rosenzweig, Margaret
    McCue, Michael
    Merriman, John D.
    Bender, Catherine M.
    SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3401 - 3409
  • [28] The association between pre-treatment occupational skill level and mood and symptom burden in early-stage, postmenopausal breast cancer survivors during the first year of anastrozole therapy
    Bethany D. Nugent
    Susan M. Sereika
    Margaret Rosenzweig
    Michael McCue
    John D. Merriman
    Catherine M. Bender
    Supportive Care in Cancer, 2016, 24 : 3401 - 3409
  • [29] Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer
    Bénédicte Mugnier
    Anthony Goncalves
    Aurélie Daumas
    Anne-Laure Couderc
    Essia Mezni
    Frédéric Viret
    Alexandre de Nonneville
    Patrick Villani
    Osteoporosis International, 2023, 34 : 703 - 711
  • [30] Aromatase inhibitors: A new reality for the adjuvant endocrine treatment of early-stage breast cancer in postmenopausal women
    Colozza, M.
    Califano, R.
    Minenza, E.
    Dinh, P.
    Azambuja, E.
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (06) : 564 - 574
12345